Biotech Stock Mailbag: Catalyst Pharma, Amarin, Star Scientific

Biotech Stock Mailbag: Catalyst Pharma, Amarin, Star Scientific
Filed under: how is cocaine addictive
The upcoming phase IIb study of CPP-109 (vigabatrin) in cocaine addiction is an important catalyst for Catalyst Pharmaceutical Partners (CPRX) but guessing the outcome is challenging. Results from the study, even if positive, may be hard to interpret. Read more on TheStreet.com